Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

VJOncology

- PMLiVE

Truthful consumerism

Amid all the change and uncertainty of this moment,  a set of core truths about our shared future is as relevant as ever

- PMLiVE

Kite files first CAR-T candidate in Europe

But will need to play catch up in the US, where Novartis has a slight lead

- PMLiVE

BMS and Clovis join forces in PARP combo race

Duo will combine Opdivo and Rubraca in phase II and III trials to treat a variety of tumours

- PMLiVE

BMS and Clovis join forces in PARP combo race

Duo will combine Opdivo and Rubraca in phase II and III trials to treat a variety of tumours

- PMLiVE

Aids related deaths almost halved since 2005, says UNAIDS

And 53% of people living with HIV now have access to treatment

- PMLiVE

It’s time to measure outcomes

Lucid launch their new metrics platform

Lucid Group Communications Limited

- PMLiVE

Raffi Asadorian joins AcelRx Pharmaceuticals

He moves from biotech firm Amyris to take up chief financial officer role

Living in fear

An evolutionary perspective reduces the risk  of missing something very important

BenevolentAI appoints new head of cheminformatics

Dr Nathan Brown joins from the Institute of Cancer Research

- PMLiVE

McCann Health cleans up at The Creative Floor Awards 2017

Agency is announced 'most awarded' while Publicis Health wins network award

Sanofi reception

Solid start for Dupixent as Sanofi raises 2017 outlook

Analysts predict dermatology medicine could become a €5bn product if approved in other indications

AstraZeneca AZ

After MYSTIC setback, FDA gives some comfort to AZ

Awards its PD-L1 inhibitor Imfinzi breakthrough status in locally-advanced NSCLC

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links